PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28836421
OWN - NLM
STAT- MEDLINE
DA  - 20170824
DCOM- 20170825
LR  - 20170828
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 8
DP  - 2017 Aug 24
TI  - Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
PG  - 789
LID - 10.1056/NEJMc1708646 [doi]
FAU - Peng, Shiqiao
AU  - Peng S
AD  - First Affiliated Hospital of China Medical University, Shenyang, China
      [email protected]
FAU - Sun, Xuren
AU  - Sun X
AD  - First Affiliated Hospital of China Medical University, Shenyang, China
      [email protected]
FAU - Sun, Mingjun
AU  - Sun M
AD  - First Affiliated Hospital of China Medical University, Shenyang, China
      [email protected]
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - FYS6T7F842 (Adalimumab)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Apr 27;376(17 ):1637-1646. PMID: 28445659
CIN - N Engl J Med. 2017 Aug 24;377(8):789-790. PMID: 28834482
MH  - *Adalimumab
MH  - *Arthritis, Juvenile
MH  - Humans
MH  - Uveitis
EDAT- 2017/08/25 06:00
MHDA- 2017/08/26 06:00
CRDT- 2017/08/25 06:00
AID - 10.1056/NEJMc1708646 [doi]
AID - 10.1056/NEJMc1708646#SA1 [pii]
PST - ppublish
SO  - N Engl J Med. 2017 Aug 24;377(8):789. doi: 10.1056/NEJMc1708646.